Can the Rangers break the Presidents’ Trophy curse? Key storylines for the 2024 Stanley Cup playoffs

Johnson & Johnson COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, the head of a trial in the country said on Friday. The J&J vaccine was administered to healthcare workers from mid-February in a research study, which was completed in May, with 477,234 health workers vaccinated, joint lead investigator on the trial Glenda Gray told a media briefing. South Africa’s health regulator approved the J&J shot in April, and it is being used in the national vaccine programme alongside Pfizer’s.